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A 43-year-old man presented with sudden onset fever and
chills. His medical history included insulin-dependent diabetes
mellitus, kidney transplant, complicated pancreas trans-
plantation that which had required transplantectomy and an
aneurysm of the arteria iliaca communis that had required
endovascular aneurysm repair.
Physical examination revealed signs of a slightly enlarged
liver. Vital signs were a respiratory rate of 16 breaths per
minute, saturation 100% (without O2), heart rate 120 beats per
minute and blood pressure 118/65 mmHg. Laboratory testing
showed C-reactive protein levels of 46 mg/L, haemoglobin
6.3 mmol/L, white blood cell count 9.3 × 109/L with 75%
neutrophils and blood platelets 236 × 109/L. Urinalysis revealed
positive leukocyte esterase, with >50 white blood count and 10
to 25 red blood cells per high-power ﬁeld. His serum creatinine
level was 205 μmol/L, and Modiﬁcation of Diet in Renal Disease
glomerular ﬁltration rate 31 mL/min/1.73 m2. Chest radiograph
revealed nothing remarkable. A bacterial infection of the uri-
nary tract was considered, and antibiotic therapy was initiated
with oral cotrimoxazole (two divided doses of 480 mg, based
on glomerular ﬁltration rate).
The next day, blood and urine cultures yielded Escherichia
hermannii (Fig. 1), identiﬁed by matrix-assisted laser desorption/
ionization time-of-ﬂight mass spectrometry (BioTyper; Bruker
Daltonics, Bremen, Germany). We sequenced an 850 bp long
fragment of the 16S rDNA gene, which revealed a 99% (849/
850 bp) match with the E. hermannii CIP 103176 type strain
(GenBank accession no. NR_104940.1). This strain was suscep-
tible to amoxicillin/clavulanic acid and resistant to amoxicillin
and ciproﬂoxacin in the Phoenix system (BD Bioscience,
Erembodegem, Belgium), applying European Committee on
Antimicrobial Susceptibility Testing clinical breakpoints. Cotri-
moxazole was switched to oral amoxicillin/clavulanic acid (3
divided doses of 625mg) for a total treatment duration of 2weeks.
Defervescence occurred in 48 hours, and the patient made a full,
uneventful recovery while receiving treatment. No relapse
occurred.
Urinary tract infections can be restricted to the bladder
(cystitis) or can spread to the kidney (pyelonephritis) and even
to the bloodstream (urosepsis). Escherichia coli is involved in
>80% of cases [1]. The association of E. hermannii with urinary
tract infections has rarely been reported. Tong et al. [2]
described a patient with pyelonephritis but without bacter-
aemia, where E. hermannii was the sole pathogen, indicating the
uropathogenic potential of this species.
E. hermannii—a Gram-negative, rod-shaped bacterium—
was ﬁrst described in 1982 and is a member of the family
Enterobacteriaceae. On the basis of phenotypic data and the
DNA hybridization technique, E. hermannii forms a distinct
species within the Escherichia genus; it produces yellow pigment
and showed only 35% to 45% DNA relatedness to E. coli [3].
E. hermannii is mainly isolated from environmental sources and
has been sporadically identiﬁed from wound, respiratory and
stool specimens [3–5]. Much is still unclear about the patho-
genicity of E. hermannii because in most cases it has been iso-
lated with other coexisting bacteria that were more pathogenic.
A possible mechanism for pathogenicity of E. hermannii is the
feature of bioﬁlm formation, which was suspected in one case
of catheter-related sepsis in a haemodialysis patient [2,6–8].
Furthermore, E. hermannii is inherently resistant to penicillin,
ampicillin and carbenicillin because of its β-lactamase produc-
tion [9]. For antibiotic treatment, β-lactams and quinolones
with in vivo susceptibility have been used [6].
In conclusion, the present case demonstrates that
E. hermannii may cause urosepsis as a sole pathogen, which
conﬁrms the uropathogenic potential of E. hermannii.
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FIG. 1. Microbiological culture of Escherichia hermannii. (A) Columbia III agar with 5% sheep’s blood (BD Bioscience). (B) MacConkey agar without salt
(BD Bioscience). (C) BankIt2056671 Escherichia_hermanii_B16064920 MG256497.
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